These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 8917020)
1. Hormone replacement therapy in the menopause: a pro opinion. Smith HO; Kammerer-Doak DN; Barbo DM; Sarto GE CA Cancer J Clin; 1996; 46(6):343-63. PubMed ID: 8917020 [TBL] [Abstract][Full Text] [Related]
2. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
7. Risk assessment of the menopausal patient. Kothari S; Thacker HL Med Clin North Am; 1999 Nov; 83(6):1489-502. PubMed ID: 10584604 [TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits? Roy JA; Sawka CA; Pritchard KI J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051 [TBL] [Abstract][Full Text] [Related]
9. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society. Menopause; 2000; 7(2):76-86. PubMed ID: 10746889 [TBL] [Abstract][Full Text] [Related]
10. Educating patients about the benefits and drawbacks of hormone replacement therapy. Rozenberg S; Vasquez JB; Vandromme J; Kroll M Drugs Aging; 1998 Jul; 13(1):33-41. PubMed ID: 9679207 [TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease. Whittington R; Faulds D Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266 [TBL] [Abstract][Full Text] [Related]
14. The benefits and risks of hormone replacement therapy: an epidemiologic overview. Harlap S Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1986-92. PubMed ID: 1605289 [TBL] [Abstract][Full Text] [Related]
15. Benefits and risks of estrogen replacement therapy. Lobo RA Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):982-9. PubMed ID: 7573295 [TBL] [Abstract][Full Text] [Related]
16. Role of hormone therapy in the management of menopause. Shifren JL; Schiff I Obstet Gynecol; 2010 Apr; 115(4):839-855. PubMed ID: 20308847 [TBL] [Abstract][Full Text] [Related]
17. MenoPAUSE: taking a second look at the role of HRT. Takiya L; Umland E J Am Pharm Assoc (2003); 2003; 43(5 Suppl 1):S34-5. PubMed ID: 14626525 [TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy in menopause: continue or stop the prescription after 10 years? There are reasons to continue hormone replacement therapy longer than 10 years]. Rozenbaum H Gynecol Obstet Fertil; 2002 Sep; 30(9):723-32. PubMed ID: 12448371 [No Abstract] [Full Text] [Related]
19. Benefits of hormone replacement therapy in postmenopausal women. Canderelli R; Leccesse LA; Miller NL; Unruh Davidson J J Am Acad Nurse Pract; 2007 Dec; 19(12):635-41. PubMed ID: 18042129 [TBL] [Abstract][Full Text] [Related]
20. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]